4BI1

Genetic Engineering

Use of Biological Resources · 6 question types

Exam Frequency Analysis

Past paper frequency (2018 to 2024)

This topic accounts for approximately 10% of your exam marks.

increasing
Medium
Increasing10%

Insulin production by bacteria and GM crops are growing in exam frequency.

Genetic engineering raises serious ethical and safety questions that scientists, governments and the public have been debating for decades. There are no simple answers.

Safety concerns

  • Could the engineered organism harm human health? GM food has been eaten by millions of people for over two decades with no clear evidence of harm, but long-term effects are uncertain.
  • Could engineered genes spread to wild populations? Pollen from GM crops can fertilise wild relatives. Genes for herbicide resistance, for example, could spread to weeds, making them harder to kill.
  • Could engineered organisms unbalance ecosystems? Bt crops kill the target pests but might also harm non-target species like butterflies that share habitat with crops.
  • Could pests evolve resistance? Yes. Insects exposed to Bt crops will be under intense selection for any Bt-resistance allele. Resistance has already been observed in some places.
  • Risk of escape: GM fish or insects released could establish wild populations that crowd out natives.

Ethical concerns

  • Playing God: some people feel humans should not deliberately alter the genome of any organism, especially across species boundaries. This concern often has religious roots.
  • Animal welfare: transgenic animals may suffer from health problems caused by their engineered genes; cloned animals often have shorter lifespans and weaker health.
  • Patents and ownership of life: companies can patent the GM organisms they create, treating living things as private property. Critics argue life should not be owned by corporations.
  • Inequality: GM seeds and patented livestock benefit large agribusinesses more than small farmers. Some farmers become dependent on annual seed purchases from a single supplier.
  • Reduced choice: cross-contamination between GM and non-GM farms can mean farmers and consumers lose the choice to avoid GM products.
  • Human gene editing: the same technology can in principle be used on human embryos. In 2018 a Chinese scientist produced the first gene-edited human babies, triggering global condemnation and tighter regulation. The line between curing disease and "designer babies" is murky.

Reasons for cautious optimism

Genetic engineering has also brought real benefits:

  • Insulin for millions of diabetics
  • Vaccines produced quickly and at low cost
  • Vitamin-enriched crops that could prevent millions of cases of malnutrition
  • Drought-tolerant crops for areas facing climate change
  • Medical research tools that have led to important discoveries
  • Conservation potential for endangered species

The regulation question

Different countries take very different approaches:

  • The USA treats GM crops mostly like any other crop, with limited labelling.
  • The European Union is more cautious: GM crops must be labelled, and many are banned from growing in EU countries.
  • The UK is currently relaxing some rules to allow more gene-edited crops.
  • Many countries in Africa and Asia have a patchwork of approaches.

Whether genetic engineering is mostly a force for good or for harm depends partly on how carefully it is regulated, who benefits from the new technology, and how transparently companies and governments handle the risks.